Post-ischemic myocardial dysfunction using thromboxane A.sub.2 antagonists
US4931460A · kind A · utility
5Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 1987 |
| Grant date | Jun 5, 1990 |
| Priority date | — |
| Expiry date | Sep 17, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for improving post-ischemic myocardial dysfunction such as contractile dysfunction or reperfusion injury by administering a thromboxane A.sub.2 antagonist before, during or immediately after an ischemic attack.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.